Product Name: PT-141 (Bremelanotide)

Dosage Form: Injectable solution or nasal spray

Strength: 10 mg

Active Ingredient: Bremelanotide

Indications: PT-141 is indicated for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. It may also be researched for enhancing sexual arousal and libido in both men and women.

Mechanism of Action: PT-141 is a melanocortin receptor agonist that primarily acts on the central nervous system to enhance sexual arousal. Unlike traditional erectile dysfunction medications, it does not directly affect blood flow but rather stimulates the brain’s pathways involved in sexual desire and arousal.

Dosage and Administration:

• The typical dose for PT-141 is 2mg, administered via subcutaneous injection or as directed by a healthcare provider.
• It is generally recommended to be taken about 45 minutes before anticipated sexual activity.
• Dosage may be adjusted based on individual response and tolerance.

Side Effects: Common side effects may include:

• Nausea
• Headache
• Flushing
• Injection site reactions
• Increased blood pressure

Warnings and Precautions:

• PT-141 should be used with caution in individuals with cardiovascular conditions due to potential increases in blood pressure.
• Not recommended for individuals with a history of hypersensitivity to the drug.
• It is important to consult with a healthcare provider prior to use, especially in patients with underlying health conditions.

Storage: Store at room temperature, away from moisture and heat. Keep out of reach of children. Once reconstituted, follow specific storage guidelines provided by the manufacturer